Concepedia

Author

W. Dunlop

Mundipharma (United Kingdom)ORCID

Also Known As

Dunlop, William C. N., W Dunlop, W. C. N. Dunlop, W. Dunlop, W.C.N. Dunlop, Will C.N. Dunlop, Will Dunlop, William C. N. Dunlop, William C.N. Dunlop, William CN Dunlop

67

Publications

802

Citations

17

H-Index

31

Concepts

All Affiliations

Mundipharma (United Kingdom)Newcastle UniversityHealth Economics and Outcomes Research (United Kingdom)Mundipharma (Germany)CACI International (United Kingdom)
WD

About

W. Dunlop is an author at Mundipharma (United Kingdom) specializing in medicine, public health, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

75

2

Public Health

2

2

42

3

Epidemiology

1

1

23

4

Family Medicine

1

1

11

5

Health Policy

1

1

31

W. Dunlop

×

18

Publications

586

Citations

15

H-Index

YearCitations

The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries

Ashok Kumar Jha, Alex Upton, W. Dunlop,

Advances in Therapy

2015

146

Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

Sue Langham, Antony Wright, James Kenworthy,

Value in Health

2018

69

Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis

W. Dunlop, Reiner Uhl, Iftekhar Khan,

Journal of Medical Economics

2012

46

Estimating the health care burden of prescription opioid abuse in five European countries

Amie Shei, Matthew Hirst, Noam Y. Kirson,

ClinicoEconomics and Outcomes Research

2015

42

Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience

W. Dunlop, Alexandra Staufer, Pierre Lévy,

Health Policy

2018

34

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

Michael P. Lux, Oriana Ciani, W. Dunlop,

Cancer Management and Research

2021

31

Cellular retinoid binding proteins and nuclear retinoic acid receptors in endometrial epithelial cells

Nadeem Siddiqui, Andrew Loughney, Eric J. Thomas,

Human Reproduction

1994

27

Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine

Alexander Hirst, C Knight, Matt Hirst,

The European Journal of Health Economics

2015

23

Factors involved in mastitis control: a comparative study between high and low incidence herds

J.K.L. Pearson, D. Greer, B. Spence,

Veterinary Record

1972

23

Bendamustine Versus Chlorambucil for the First-Line Treatment of Chronic Lymphocytic Leukemia in England and Wales: A Cost-Utility Analysis

Beth Woods, Neil Hawkins, W. Dunlop,

Value in Health

2012

23

Page 1